Efficacy and Safety of Budesonide, vs Mesalazine or Placebo, as Induction Therapy for Lymphocytic Colitis
Stephan Miehlke(University Medical Center Hamburg-Eppendorf), Wolfgang Kruis(ThyssenKrupp (Germany)), M Hoesl, Limas Kupčinskas(Lithuanian University of Health Sciences), Ahmed Madisch(Technische Universität Dresden), Johan Bohr(Örebro University Hospital), Fernando Fernández‐Bañares, Greger Lindberg(Karolinska Institutet), T. Rannem, Marieke Pierik(Maastricht University Medical Centre), Ole K. Bonderup(Aarhus University), Zsolt Tulassay(Semmelweis University), Andreas Münch(Linköping University), Daniela E. Aust(University Hospital Carl Gustav Carus), Michael Bläker, Alfredo J. Lucendo(Hospital General de Tomelloso), Jiri Stehlk, Martin Krauß(Helmholtz Centre for Environmental Research), Lina Vigren(Malmö University), Juozas Kupčinskas(Lithuanian University of Health Sciences), Per M. Hellström(Uppsala University), Lars Kristian Munck(Zealand University Hospital), F Zsigmond, Tanju Nacak(Dr Falk Pharma (Germany)), Eberhard Meier, Kai-Uwe Rehbehn(Städtisches Klinikum Solingen), Roland Greinwald(Dr Falk Pharma (Germany)), Ferenc Nagy, Axel Dignaß, Christian Kirsch, Gerd Bouma(Amsterdam University Medical Centers), Günter Böhm(Ludwigshafen University of Business and Society), G Kiss, Barbro Lebrun, M Wielondek, Emese Mihály(Semmelweis University), Peter Armerding(Pathodiagnostik Berlin)
Cited by 70
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k